PMID- 19439225 OWN - NLM STAT- MEDLINE DCOM- 20091113 LR - 20211203 IS - 1873-4596 (Electronic) IS - 0891-5849 (Linking) VI - 46 IP - 8 DP - 2009 Apr 15 TI - Activating transcription factor 4 and CCAAT/enhancer-binding protein-beta negatively regulate the mammalian target of rapamycin via Redd1 expression in response to oxidative and endoplasmic reticulum stress. PG - 1158-67 LID - 10.1016/j.freeradbiomed.2009.01.015 [doi] AB - Regulation of mRNA translation in mammalian cells involves the coordinated control of mammalian target of rapamycin (mTOR) signaling. At present, limited information is available on the potential relevance of mTOR regulation, although translation inhibition during oxidative and endoplasmic reticulum (ER) stress is clearly important. In this study, we show that activating transcription factor 4 (ATF4) and CCAAT/enhancer-binding protein-beta (C/EBP-beta) negatively regulate mTOR via Redd1 expression in response to oxidative and ER stress. Oxidative and ER stress conditions induce rapid and significant activation of ATF4 downstream of eIF2alpha phosphorylation, which is responsible for Redd1 expression. In our experiment, overexpression of ATF4 was associated with reduced mTOR activity via Redd1 expression, whereas suppression of ATF4 levels with small interfering RNA led to the recovery of decreased mTOR activity mediated by downregulation of Redd1 during oxidative and ER stress. We additionally identified Redd1 as a downstream effector of C/EBP-beta stimulated by ATF4 activated under the stress conditions examined. RNA interference studies provided further evidence of the requirement of C/EBP-beta for Redd1 expression. We conclude that the Redd1 gene is transactivated by the ATF4 and C/EBP family of transcription factors, leading to mTOR inhibition in response to oxidative and ER stress. FAU - Jin, Hyeon-Ok AU - Jin HO AD - Division of Radiation Cancer Research, Korea Institute of Radiological & Medical Sciences, Nowon-gu, Seoul, Republic of Korea. FAU - Seo, Sung-Keum AU - Seo SK FAU - Woo, Sang-Hyeok AU - Woo SH FAU - Kim, Eun-Sung AU - Kim ES FAU - Lee, Hyung-Chahn AU - Lee HC FAU - Yoo, Doo-Hyun AU - Yoo DH FAU - An, Sungkwan AU - An S FAU - Choe, Tae-Boo AU - Choe TB FAU - Lee, Su-Jae AU - Lee SJ FAU - Hong, Seok-Il AU - Hong SI FAU - Rhee, Chang-Hun AU - Rhee CH FAU - Kim, Jong-Il AU - Kim JI FAU - Park, In-Chul AU - Park IC LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090127 PL - United States TA - Free Radic Biol Med JT - Free radical biology & medicine JID - 8709159 RN - 0 (ATF4 protein, human) RN - 0 (CCAAT-Enhancer-Binding Protein-beta) RN - 0 (DDIT4 protein, human) RN - 0 (RNA, Small Interfering) RN - 0 (Transcription Factors) RN - 145891-90-3 (Activating Transcription Factor 4) RN - BBX060AN9V (Hydrogen Peroxide) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - W36ZG6FT64 (Sirolimus) SB - IM MH - Activating Transcription Factor 4/genetics/metabolism/*physiology MH - CCAAT-Enhancer-Binding Protein-beta/*physiology MH - Endoplasmic Reticulum MH - Feedback, Physiological MH - HeLa Cells MH - Humans MH - Hydrogen Peroxide/metabolism MH - Oxidative Stress MH - Protein Kinases/genetics/metabolism MH - RNA, Small Interfering/genetics MH - Signal Transduction MH - Sirolimus/metabolism MH - TOR Serine-Threonine Kinases MH - Transcription Factors/genetics/*metabolism MH - *Transcriptional Activation EDAT- 2009/05/15 09:00 MHDA- 2009/11/17 06:00 CRDT- 2009/05/15 09:00 PHST- 2008/09/05 00:00 [received] PHST- 2009/01/20 00:00 [revised] PHST- 2009/01/21 00:00 [accepted] PHST- 2009/05/15 09:00 [entrez] PHST- 2009/05/15 09:00 [pubmed] PHST- 2009/11/17 06:00 [medline] AID - S0891-5849(09)00054-9 [pii] AID - 10.1016/j.freeradbiomed.2009.01.015 [doi] PST - ppublish SO - Free Radic Biol Med. 2009 Apr 15;46(8):1158-67. doi: 10.1016/j.freeradbiomed.2009.01.015. Epub 2009 Jan 27.